SCHEMBL6723786

SCHEMBL6723786

NCCCNCCC(N)CCN

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.55
CA6 P23280 5/20 0.55
CA7 P43166 5/20 0.55
CA9 Q16790 5/20 0.55
CA14 Q9ULX7 5/20 0.55
CA5B Q9Y2D0 5/20 0.55
CA2 P00918 4/20 0.55
CA4 P22748 4/20 0.55
CA5A P35218 4/20 0.55
ALOX15 P16050 3/20 0.55
CASP2 P42575 2/20 0.55
F13A1 P00488 2/20 0.55
CYP1A2 P05177 2/20 0.55
THPO P40225 2/20 0.55
MEN1 O00255 2/20 0.55
RECQL P46063 2/20 0.55
KMT2A Q03164 2/20 0.55
CYP2C19 P33261 1/20 0.55
HSD17B10 Q99714 1/20 0.55
CA3 P07451 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18316003 0.98 CASP2 (0.59) CA12CA6CA7CA9CA14
SCHEMBL23924138 0.91 CA12 (0.55) CA12CA6CA7CA9CA14
SCHEMBL117478 0.91 CA12 (0.62) CA12CA6CA7CA9CA14
SCHEMBL1177482 0.91 CA12 (0.55) CA12CA6CA7CA9CA14
SCHEMBL30893657 0.90 CA12 (0.42) CA12CA6CA7CA9CA14
SCHEMBL8699212 0.88 CA12 (0.59) CA12CA6CA7CA9CA14
SCHEMBL30867218 0.88 CA12 (0.52) CA12CA6CA7CA9CA14
SCHEMBL3069983 0.88 CA12 (0.52) CA12CA6CA7CA9CA14
SCHEMBL21045082 0.88 CASP2 (0.59) CA12CA6CA7CA9CA14
SCHEMBL8616879 0.87 CA12 (0.45) CA12CA6CA7CA9CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119504628-A Synthetic method of pleshafu impurity 北京沣瑞医药科技有限公司 2025-02-25 CN claimed
CN-118591450-A Polymer composition with densification promoter and rotational molding method for manufacturing hollow article therefrom 塞特工业公司 2024-09-03 CN claimed
CN-107750260-A Aldehyde for polyurethane foam removes agent composition 赢创德固赛有限公司 2018-03-02 CN claimed
US-20160369035-A1 ALDEHYDE SCAVENGERS MIXTURES FOR POLYURETHANE FOAMS AIR PRODUCTS AND CHEMICALS, INC. (US) 2016-12-22 US claimed
CN-119504628-A Synthetic method of pleshafu impurity 北京沣瑞医药科技有限公司 2025-02-25 CN disclosed
CN-118591450-A Polymer composition with densification promoter and rotational molding method for manufacturing hollow article therefrom 塞特工业公司 2024-09-03 CN disclosed
CN-118302243-A The amine being attached to the metal-organic skeleton 埃克森美孚技术与工程公司 2024-07-05 CN disclosed
US-10696777-B2 Aldehyde scavengers mixtures for polyurethane foams EVONIK OPERATIONS GMBH (DE) 2020-06-30 US disclosed
CN-107750260-A Aldehyde for polyurethane foam removes agent composition 赢创德固赛有限公司 2018-03-02 CN disclosed
US-20160369035-A1 ALDEHYDE SCAVENGERS MIXTURES FOR POLYURETHANE FOAMS AIR PRODUCTS AND CHEMICALS, INC. (US) 2016-12-22 US disclosed
US-6677451-B2 POLYMER STABILIZERS; OXYGEN, HEAT, RADIATION RESISTANCES; DISCOLORATION INHIBITION; COATINGS; FIBERS; TAPES; FILMS; PAPERMAKING; HALS; FIREPROOFING; OXIDATION OF A 1-ALLYL-SUBSTITUTED STERICALLY HINDERED AMINE CIBA SPECIALTY CHEMICALS CORPORATION 2004-01-13 US disclosed
US-20020094976-A1 Preparation of sterically hindered amine ethers ZEDDA ALESSANDRO (IT) 2002-07-18 US disclosed
US-6420462-B1 OXIDATION RESISTANCE, HEAT RESISTANT AND ACTINIC DEGRADATIONHETEROCYCLIC AMINE OXIDES CIBA SPECIALTY CHEMICALS CORPORATION 2002-07-16 US disclosed
US-6117995-A OXIDATION OF THE CORRESPONDING HETEROCYCLIC AMINE COMPOUND CIBA SPECIALTY CHEMICALS CORPORATION (US) 2000-09-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094976-A1 Preparation of sterically hindered amine ethers CBR1, CBR3, RER1 CA12 1504/4885CA6 1436/4885CA7 1148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.